Novonix Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-46.25	-51.86	-13.45	-13.43	-18.94
Other Operating Activities	10.02	22.63	7.36	9.68	16.04
Operating Cash Flow	-36.23	-29.23	-6.09	-3.75	-2.9
Capital Expenditures	-19.2	-83.76	-19.58	-3.68	-1.56
Acquisitions	0	0	0	0	-3.77
Change in Investments	0	-12.77	0	0	0
Other Investing Activities	7.46	-10.27	-0.1	-0.01	-0
Investing Cash Flow	-11.74	-106.8	-19.68	-3.69	-5.33
Share Issuance / Repurchase	0.33	150.83	100.95	30.84	0
Debt Issued / Paid	29.28	32.36	2.82	-0.36	12.22
Other Financing Activities	-0.3	-2.5	-	-	-
Financing Cash Flow	29.31	180.69	103.77	30.48	12.22
Net Cash Flow	-18.65	44.66	78	23.04	3.99
Free Cash Flow	-55.42	-112.99	-25.66	-7.43	-4.46
Free Cash Flow Margin	-688.11%	-1851.97%	-659.13%	-260.47%	-338.92%
Free Cash Flow Per Share	-0.46	-0.97	-0.28	-0.22	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).